Recommendations for the diagnosis and treatment of the acute porphyrias
- PMID: 15767622
- DOI: 10.7326/0003-4819-142-6-200503150-00010
Recommendations for the diagnosis and treatment of the acute porphyrias
Erratum in
- Ann Intern Med. 2005 Aug 16;143(4):316
Abstract
The acute porphyrias, 4 inherited disorders of heme biosynthesis, cause life-threatening attacks of neurovisceral symptoms that mimic many other acute medical and psychiatric conditions. Lack of clinical recognition often delays effective treatment, and inappropriate diagnostic tests may lead to misdiagnosis and inappropriate treatment. We review the clinical manifestations, pathophysiology, and genetics of the acute porphyrias and provide recommendations for diagnosis and treatment on the basis of reviews of the literature and clinical experience. An acute porphyria should be considered in many patients with unexplained abdominal pain or other characteristic symptoms. The diagnosis can be rapidly confirmed by demonstration of a markedly increased urinary porphobilinogen level by using a single-void urine specimen. This specimen should also be saved for quantitative measurement of porphobilinogen, 5-aminolevulinic acid, and total porphyrin levels. Intravenous hemin therapy, started as soon as possible, is the most effective treatment. Intravenous glucose alone is appropriate only for mild attacks (mild pain, no paresis or hyponatremia) or until hemin is available. Precipitating factors should be eliminated, and appropriate supportive and symptomatic therapy should be initiated. Prompt diagnosis and treatment greatly improve prognosis and may prevent development of severe or chronic neuropathic symptoms. We recommend identification of at-risk relatives through enzymatic or gene studies.
Similar articles
-
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.Orphanet J Rare Dis. 2022 Apr 7;17(1):160. doi: 10.1186/s13023-022-02314-9. Orphanet J Rare Dis. 2022. PMID: 35392955 Free PMC article. Review.
-
Neurovisceral porphyrias: what a hematologist needs to know.Hematology Am Soc Hematol Educ Program. 2005:24-30. doi: 10.1182/asheducation-2005.1.24. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304355
-
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.Gastroenterology. 2023 Mar;164(3):484-491. doi: 10.1053/j.gastro.2022.11.034. Epub 2023 Jan 13. Gastroenterology. 2023. PMID: 36642627 Free PMC article. Review.
-
A family with acute intermittent porphyria.J Coll Physicians Surg Pak. 2008 May;18(5):316-8. J Coll Physicians Surg Pak. 2008. PMID: 18541093
-
[Porphyrias].Internist (Berl). 2010 Dec;51(12):1525-33; quiz 1534. doi: 10.1007/s00108-010-2751-x. Internist (Berl). 2010. PMID: 21104216 Review. German.
Cited by
-
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.Orphanet J Rare Dis. 2022 Apr 7;17(1):160. doi: 10.1186/s13023-022-02314-9. Orphanet J Rare Dis. 2022. PMID: 35392955 Free PMC article. Review.
-
Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone.Mol Pharmacol. 2010 Apr;77(4):575-92. doi: 10.1124/mol.109.061259. Epub 2010 Jan 13. Mol Pharmacol. 2010. Retraction in: Mol Pharmacol. 2021 Aug;100(2):65. doi: 10.1124/mol.109.061259retraction. PMID: 20071449 Free PMC article. Retracted.
-
Porphyrie aiguë se manifestant sous forme de douleur abdominale durant la grossesse.CMAJ. 2021 Jun 14;193(24):E931-E934. doi: 10.1503/cmaj.202384-f. CMAJ. 2021. PMID: 34860694 Free PMC article. French. No abstract available.
-
Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.Front Immunol. 2018 Mar 1;9:179. doi: 10.3389/fimmu.2018.00179. eCollection 2018. Front Immunol. 2018. PMID: 29545789 Free PMC article.
-
Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.J Inherit Metab Dis. 2019 Jan;42(1):186-194. doi: 10.1002/jimd.12040. J Inherit Metab Dis. 2019. PMID: 30740734 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical